Associations between complications and health-related quality of life in individuals with diabetes

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 865-873

  Venkataraman, K ^a   Wee, H L ^b,c   Leow, M K S ^d,e   Tai, E S ^f   Lee, J ^b   Lim, S C ^b   Tavintharan, S ^b,g   Wong, T Y ^b   Ma, S ^h   Heng, D ^h   Thumboo, J ^c,f  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d AGENCY FOR SCIENCE   (Singapore)

^e TAN TOCK SENG HOSPITAL   (Singapore)

^f Dept Medicine Endocrinol Diabet   (Singapore)

^g KHOO TECK PUAT HOSPITAL   (Singapore)

^h MINISTRY OF HEALTH   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL COMPONENT SCORE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; SINGAPORE;

CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SINGAPORE;

EID: 84876547572     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04480.x     Document Type: Article

References (60)

1. IDF (2009) IDF Diabetes Atlas. International Diabetes Federation, Brussels.
2. WHO (2011) Global Status Report on Noncommunicable Diseases 2010. World Health Organization, Geneva.
3. Rubin, R.R., &, Peyrot, M., (1999) Quality of life and diabetes. Diabetes/Metabolism Research and Reviews, 15, 205-218.
4. WHO (1997) WHOQOL Measuring Quality of Life. Programme on Mental Health. World Health Organization, Geneva.
5. Maddigan, S.L., Feeny, D.H., Majumdar, S.R., et al,. (2006) Understanding the determinants of health for people with type 2 diabetes. American Journal of Public Health, 96, 1649-1655.
6. Davidov, E., Breitscheidel, L., Clouth, J., et al,. (2009) Diabetic retinopathy and health-related quality of life. Graefes Archive for Clinical and Experimental Ophthalmology, 247, 267-272.
7. Happich, M., John, J., Stamenitis, S., et al,. (2008) The quality of life and economic burden of neuropathy in diabetic patients in Germany in 2002-results from the Diabetic Microvascular Complications (DIMICO) study. Diabetes Research and Clinical Practice, 81, 223-230.
8. Sorensen, V.R., Mathiesen, E.R., Watt, T., et al,. (2007) Diabetic patients treated with dialysis: complications and quality of life. Diabetologia, 50, 2254-2262.
9. U.K.P.D.S. (1999) Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care, 22, 1125-1136.
10. Holmes, J., McGill, S., Kind, P., et al,. (2000) Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health, 3 (Suppl 1), 47-51.
11. Papadopoulos, A.A., Kontodimopoulos, N., Frydas, A., et al,. (2007) Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health, 7, 186.
12. Coffey, J.T., Brandle, M., Zhou, H., et al,. (2002) Valuing health-related quality of life in diabetes. Diabetes Care, 25, 2238-2243.
13. Wexler, D.J., Grant, R.W., Wittenberg, E., et al,. (2006) Correlates of health-related quality of life in type 2 diabetes. Diabetologia, 49, 1489-1497.
14. Solli, O., Stavem, K., &, Kristiansen, I.S., (2010) Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health and Quality of Life Outcomes, 8, 18.
15. Quah, J.H., Luo, N., Ng, W.Y., et al,. (2011) Health-related quality of life is associated with diabetic complications, but not with short-term diabetic control in primary care. Annals of the Academy of Medicine, Singapore, 40, 276-286.
16. Maatouk, I., Wild, B., Wesche, D., et al,. (2012) Temporal predictors of health-related quality of life in elderly people with diabetes: results of a German cohort study. PLoS One, 7, e31088.
17. Wee, H.L., Cheung, Y.B., Li, S.C., et al,. (2005) The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: is the whole greater than the sum of its parts? Health and Quality of Life Outcomes, 3, 2.
18. Alonso, J., Ferrer, M., Gandek, B., et al,. (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13, 283-298.
19. Maddigan, S.L., Feeny, D.H., &, Johnson, J.A., (2005) Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Quality of Life Research, 14, 1311-1320.
20. Heyworth, I.T., Hazell, M.L., Linehan, M.F., et al,. (2009) How do common chronic conditions affect health-related quality of life? British Journal of General Practice, 59, e353-e358.
21. Poljicanin, T., Ajdukovic, D., Sekerija, M., et al,. (2010) Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life. BMC Public Health, 10, 12.
22. Gough, S.C., Kragh, N., Ploug, U.J., et al,. (2009) Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2, 179-184.
23. Sprangers, M.A., de Regt, E.B., Andries, F., et al,. (2000) Which chronic conditions are associated with better or poorer quality of life? Journal of Clinical Epidemiology, 53, 895-907.
24. Ose, D., Miksch, A., Urban, E., et al,. (2011) Health related quality of life and comorbidity. A descriptive analysis comparing EQ-5D dimensions of patients in the German disease management program for type 2 diabetes and patients in routine care. BMC Health Services Research, 11, 179.
25. Hughes, K., Yeo, P.P., Lun, K.C., et al,. (1990) Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. Journal of Epidemiology and Community Health, 44, 29-35.
26. Tan, C.E., Emmanuel, S.C., Tan, B.Y., et al,. (1999) Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care, 22, 241-247.
27. Hughes, K., Aw, T.C., Kuperan, P., et al,. (1997) Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. Journal of Epidemiology and Community Health, 51, 394-399.
28. Cutter, J., Tan, B.Y., &, Chew, S.K., (2001) Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bulletin of the World Health Organization, 79, 908-915.
29. Nang, E.E., Khoo, C.M., Tai, E.S., et al,. (2009) Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease? The Singapore Prospective Study Program. American Journal of Epidemiology, 169, 1454-1462.
30. Sabanayagam, C., Tai, E.S., Shankar, A., et al,. (2009) Retinal arteriolar narrowing increases the likelihood of chronic kidney disease in hypertension. Journal of Hypertension, 27, 2209-2217.
31. Thumboo, J., Fong, K.Y., Chan, S.P., et al,. (1999) Validation of the medical outcomes study family and marital functioning measures in SLE patients in Singapore. Lupus, 8, 514-520.
32. Ware, J., Kosinki, M., Bjorner, J., et al,. (2007) User's Manual for the SF-36v2 Health Survey, 2nd edn. QualityMetric Inc., Lincoln, RI.
33. Brazier, J., Roberts, J., &, Deverill, M., (2002) The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271-292.
34. Wong, T.Y., Cheung, N., Tay, W.T., et al,. (2008) Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology, 115, 1869-1875.
35. Chiang, P.P., Lamoureux, E.L., Cheung, C.Y., et al,. (2011) Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic Asian population. Investigative Ophthalmology & Visual Science, 52, 7586-7592.
36. Young, M.J., Breddy, J.L., Veves, A., et al,. (1994) The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care, 17, 557-560.
37. Kumar, S., Fernando, D.J., Veves, A., et al,. (1991) Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Research and Clinical Practice, 13, 63-67.
38. Lavery, L.A., Armstrong, D.G., Vela, S.A., et al,. (1998) Practical criteria for screening patients at high risk for diabetic foot ulceration. Archives of Internal Medicine, 158, 157-162.
39. Pham, H., Armstrong, D.G., Harvey, C., et al,. (2000) Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care, 23, 606-611.
40. Levey, A.S., Coresh, J., Balk, E., et al,. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of Internal Medicine, 139, 137-147.
41. Clarke, P., Gray, A., &, Holman, R., (2002) Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22, 340-349.
42. Lung, T.W., Hayes, A.J., Hayen, A., et al,. (2011) A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Quality of Life Research, 20, 1669-1678.
43. Benbow, S.J., Wallymahmed, M.E., &, MacFarlane, I.A., (1998) Diabetic peripheral neuropathy and quality of life. QJM, 91, 733-737.
44. Van Acker, K., Bouhassira, D., De Bacquer, D., et al,. (2009) Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes & Metabolism, 35, 206-213.
45. Currie, C.J., Poole, C.D., Woehl, A., et al,. (2006) The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia, 49, 2272-2280.
46. Ovayolu, N., Akarsu, E., Madenci, E., et al,. (2008) Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life. International Journal of Clinical Practice, 62, 1019-1025.
47. Saito, I., Inami, F., Ikebe, T., et al,. (2006) Impact of diabetes on health-related quality of life in a population study in Japan. Diabetes Research and Clinical Practice, 73, 51-57.
48. de Groot, M., Anderson, R., Freedland, K.E., et al,. (2001) Association of depression and diabetes complications: a meta-analysis. Psychosomatic Medicine, 63, 619-630.
49. Patel, A., MacMahon, S., Chalmers, J., et al,. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358, 2560-2572.
50. Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., et al,. (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ, 343, d4169.
51. Heng, B.H., Sun, Y., Cheah, J.T., et al,. (2010) The Singapore National Healthcare Group Diabetes Registry-descriptive epidemiology of type 2 diabetes mellitus. Annals of the Academy of Medicine, Singapore, 39, 348-352.
52. Mafauzy, M., Hussein, Z., &, Chan, S.P., (2011) The status of diabetes control in Malaysia: results of DiabCare 2008. Medical Journal of Malaysia, 66, 175-181.
53. Wong, K., Glovaci, D., Malik, S., et al,. (2012) Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. Journal of Diabetes and Its Complications, 26, 169-174.
54. Okafor, C.I., &, Ofoegbu, E.N., (2012) Control to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus. Nigerian Journal of Clinical Practice, 15, 15-18.
55. Chew, E.Y., Ambrosius, W.T., Davis, M.D., et al,. (2010) Effects of medical therapies on retinopathy progression in type 2 diabetes. New England Journal of Medicine, 363, 233-244.
56. Rajamani, K., Colman, P.G., Li, L.P., et al,. (2009) Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet, 373, 1780-1788.
57. Davis, T.M., Ting, R., Best, J.D., et al,. (2000) Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia, 54, 280-290.
58. American Diabetes Association (2012) Standards of medical care in diabetes-2012. Diabetes Care, 35 (Suppl 1), S11-S63.
59. Bril, V., England, J., Franklin, G.M., et al,. (2011) Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology, 76, 1758-1765.
60. Zilliox, L., &, Russell, J.W., (2011) Treatment of diabetic sensory polyneuropathy. Current Treatment Options in Neurology, 13, 143-159.